dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Tarantino, Paolo |
dc.contributor.author | Corti, Chiara |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Mittendorf, Elizabeth |
dc.contributor.author | Schmid, Peter |
dc.contributor.author | Rugo, Hope |
dc.date.accessioned | 2022-07-20T10:30:46Z |
dc.date.available | 2022-07-20T10:30:46Z |
dc.date.issued | 2022-02-18 |
dc.identifier.citation | Tarantino P, Corti C, Schmid P, Cortes J, Mittendorf EA, Rugo H, et al. Immunotherapy for early triple negative breast cancer: research agenda for the next decade. NPJ Breast Cancer. 2022 Feb 18;8:23. |
dc.identifier.issn | 2374-4677 |
dc.identifier.uri | https://hdl.handle.net/11351/7875 |
dc.description | Càncer de mama; Desenvolupament de medicaments; Immunoedició |
dc.description.sponsorship | Supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | NPJ Breast Cancer;8 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject | Immunoteràpia |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.title | Immunotherapy for early triple negative breast cancer: research agenda for the next decade |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41523-022-00386-1 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.1038/s41523-022-00386-1 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Tarantino P] Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy. [Corti C] Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. [Schmid P] Barts Cancer Institute, Queen Mary University of London, London, UK. [Cortes J] Oncology Department, International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Breast Cancer Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. [Mittendorf EA] Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, USA. Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA. [Rugo H] University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, USA |
dc.identifier.pmid | 35181659 |
dc.identifier.wos | 000757838000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |